Hypomorphic pathogenic variant in SFTPB leads to adult pulmonary fibrosis.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
09 2023
Historique:
received: 12 12 2022
accepted: 12 06 2023
revised: 25 05 2023
pmc-release: 01 09 2024
medline: 4 9 2023
pubmed: 29 6 2023
entrez: 28 6 2023
Statut: ppublish

Résumé

Biallelic pathogenic variants in the surfactant protein (SP)-B gene (SFTPB) have been associated with fatal forms of interstitial lung diseases (ILD) in newborns and exceptional survival in young children. We herein report the cases of two related adults with pulmonary fibrosis due to a new homozygous SFTPB pathogenic variant, c.582G>A p.(Gln194=). In vitro transcript studies showed that this SFTPB synonymous pathogenic variant induces aberrant splicing leading to three abnormal transcripts with the preservation of the expression of a small proportion of normal SFTPB transcripts. Immunostainings on lung biopsies of the proband showed an almost complete loss of SP-B expression. This hypomorphic splice variant has thus probably allowed the patients' survival to adulthood while inducing an epithelial cell dysfunction leading to ILD. Altogether, this report shows that SFTPB pathogenic variants should be considered in atypical presentations and/or early-onset forms of ILD particularly when a family history is identified.

Identifiants

pubmed: 37380697
doi: 10.1038/s41431-023-01413-w
pii: 10.1038/s41431-023-01413-w
pmc: PMC10474257
doi:

Substances chimiques

Pulmonary Surfactant-Associated Protein B 0
SFTPB protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1083-1087

Informations de copyright

© 2023. The Author(s), under exclusive licence to European Society of Human Genetics.

Références

Ann Thorac Med. 2022 Apr-Jun;17(2):132-135
pubmed: 35651895
Curr Opin Pulm Med. 2018 May;24(3):253-259
pubmed: 29517585
J Biol Chem. 2003 Dec 5;278(49):49006-14
pubmed: 13129928
Am J Respir Cell Mol Biol. 2022 Jul;67(1):20-35
pubmed: 35294321
Arch Dis Child. 2013 Jul;98(7):490-5
pubmed: 23625987
AJP Rep. 2015 Apr;5(1):e53-9
pubmed: 26199800
J Pediatr. 2006 Oct;149(4):548-53
pubmed: 17011330
Am J Physiol Lung Cell Mol Physiol. 2005 Jun;288(6):L1154-61
pubmed: 15722377
Semin Perinatol. 2006 Dec;30(6):316-26
pubmed: 17142157
J Clin Invest. 1994 Apr;93(4):1860-3
pubmed: 8163685
Eur Respir Rev. 2021 Feb 16;30(159):
pubmed: 33597124
Proc Am Thorac Soc. 2011 May;8(2):158-62
pubmed: 21543794
Hum Mutat. 2022 Dec;43(12):2091-2101
pubmed: 36135709
Pediatr Res. 2000 Sep;48(3):275-82
pubmed: 10960490
J Clin Invest. 2020 Oct 1;130(10):5088-5099
pubmed: 32870817
N Engl J Med. 1993 Feb 11;328(6):406-10
pubmed: 8421459
Pediatrics. 1995 Dec;96(6):1046-52
pubmed: 7491219
J Pediatr. 2017 May;184:157-164.e2
pubmed: 28215425
J Biol Chem. 2004 Apr 16;279(16):16178-84
pubmed: 14766755
Orphanet J Rare Dis. 2012 Jun 15;7:40
pubmed: 22704798
J Pediatr. 2017 Nov;190:268-270.e1
pubmed: 28888561

Auteurs

Tifenn Desroziers (T)

Inserm UMR_S933, Laboratory of Childhood Genetic Diseases, Armand Trousseau Hospital, Sorbonne Université, Paris, France.

Grégoire Prévot (G)

Respiratory Medicine, Toulouse University Hospital, Toulouse, France.

Aurore Coulomb (A)

Assistance Publique - Hôpitaux de Paris, Pathology Department, Armand Trousseau Hospital, Sorbonne Université, Paris, France.

Valérie Nau (V)

Assistance Publique - Hôpitaux de Paris, Molecular Genetics Unit, Armand Trousseau Hospital, Sorbonne Université, Paris, France.

Florence Dastot-Le Moal (F)

Assistance Publique - Hôpitaux de Paris, Molecular Genetics Unit, Armand Trousseau Hospital, Sorbonne Université, Paris, France.

Philippe Duquesnoy (P)

Inserm UMR_S933, Laboratory of Childhood Genetic Diseases, Armand Trousseau Hospital, Sorbonne Université, Paris, France.

Mélanie Héry (M)

Inserm UMR_S933, Laboratory of Childhood Genetic Diseases, Armand Trousseau Hospital, Sorbonne Université, Paris, France.

Aurélie Le Borgne (A)

Respiratory Medicine, Toulouse University Hospital, Toulouse, France.

Serge Amselem (S)

Inserm UMR_S933, Laboratory of Childhood Genetic Diseases, Armand Trousseau Hospital, Sorbonne Université, Paris, France.
Assistance Publique - Hôpitaux de Paris, Molecular Genetics Unit, Armand Trousseau Hospital, Sorbonne Université, Paris, France.

Marie Legendre (M)

Inserm UMR_S933, Laboratory of Childhood Genetic Diseases, Armand Trousseau Hospital, Sorbonne Université, Paris, France.
Assistance Publique - Hôpitaux de Paris, Molecular Genetics Unit, Armand Trousseau Hospital, Sorbonne Université, Paris, France.

Nadia Nathan (N)

Inserm UMR_S933, Laboratory of Childhood Genetic Diseases, Armand Trousseau Hospital, Sorbonne Université, Paris, France. nadia.nathan@aphp.fr.
Assistance Publique - Hôpitaux de Paris, Pediatric Pulmonology Department and Reference Center for Rare Lung Diseases RespiRare, Armand Trousseau Hospital, Sorbonne Université, Paris, France. nadia.nathan@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH